Antimicrobial Composition Cationic Polymer Synergy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antimicrobial agents face challenges in achieving superior microbicidal efficacy and malodor control, particularly in disinfection applications, where enhanced performance and prolonged antimicrobial effects are desired.

Innovation Solution

A combination of cationic polymers with specific molecular weights and antimicrobial agents such as halophenols, nitrophenols, bisphenols, or quaternary ammonium compounds, along with surfactants and thickening agents, is used to create a formulation that improves antimicrobial performance and malodor control, suitable for various consumer products.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional antimicrobial agents are used alone, then the formulation is simple, but the microbicidal efficacy and malodor control performance are insufficient

Engineering Contradiction:
Improvemicrobicidal efficacyVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent combines cationic polymers with specific antimicrobial agents (halophenols, nitrophenols, bisphenols, or quaternary ammonium compounds) to create a synergistic formulation. This merging of components enhances microbicidal efficacy and malodor control performance beyond what single agents can achieve alone, directly resolving the contradiction between simplicity and effectiveness.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention uses composite material formulations consisting of cationic polymers and antimicrobial agents. This composite approach allows the formulation to achieve superior antimicrobial performance and prolonged effect duration while maintaining manageable complexity through defined component relationships and concentration ranges.

Inventive Principle:
Principle #40Composite materials

2Reliability

If higher concentrations of antimicrobial agents are used, then the microbicidal efficacy is improved, but the safety and potential harm to users increases

Engineering Contradiction:
Improveantimicrobial performanceVSAvoiduser safety
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent optimizes the molecular weight parameters of cationic polymers (specifically polyquaternium-2 with defined molecular weight ranges) and adjusts concentration parameters of antimicrobial agents to achieve effective antimicrobial performance while minimizing harmful effects. This parameter optimization allows high efficacy at lower, safer concentrations.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

Cationic polymers act as intermediaries that enhance the effectiveness of antimicrobial agents, allowing lower concentrations of active antimicrobial components to achieve the desired effect. This mediator approach reduces direct exposure to high concentrations of potentially harmful antimicrobial agents while maintaining superior microbicidal efficacy.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Duration of action of stationary object

If short-acting antimicrobial agents are used, then the formulation is simpler, but the duration of antimicrobial effect is insufficient

Engineering Contradiction:
Improveantimicrobial effect durationVSAvoidformulation complexity
Core Design Contradiction:
Duration of action of stationary objectVSDevice complexity

Solution Approach 1:

The combination of cationic polymers with antimicrobial agents creates a formulation where the polymer provides prolonged release and sustained activity. This merging extends the duration of antimicrobial effect significantly compared to using short-acting agents alone, while the formulation remains manageable through defined component specifications.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS20240376402A1Antimicrobial composition and the formulation comprising the same
Publication Date: 2024.11.14 SPECIALTY OPERATIONS FRANCE
  • US20240376402A1 patent drawing
  • US20240376402A1 patent drawing
  • US20240376402A1 patent drawing

AI summary

The present disclosure relates to an antimicrobial composition comprising a first antimicrobial agent selected from the group consisting of benzalkonium salts, Triclocarban, Diclosan, Triclosan, or the combination thereof; and a second antimicrobial agent which is the cationic polymer having a weight average molecular weight of 1,000 to 50,000 represented by general formula (I). The present disclosure further relates to a personal care composition comprising the same.